Showing results (31-40 of 40) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Prostate Cancer and Prostatic Diseases|January 11, 2022
Definitions of disease burden across the spectrum of metastatic castration-sensitive prostate cancer: comparison by disease outcomes and genomicsPhilip Sutera, Kim Van Der Eecken, Amar U Kishan, et al.International Journal of Radiation Oncology, Biology, Physics|February 18, 2017
Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III TrialDaniel A Hamstra, Neil Mariados, John Sylvester, et al.International Journal of Radiation Oncology, Biology, Physics|January 28, 2023
WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate CancerPhilip Sutera, Matthew P Deek, Kim Van der Eecken, et al.The Prostate|October 9, 2023
TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatmentTung Hoang, Philip Sutera, Triet Nguyen, et al.Practical Radiation Oncology|September 28, 2017
Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trialDaniel A Hamstra, Neil Mariados, John Sylvester, et al.European Urology|May 12, 2023
Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Kim Van der Eecken, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 7, 2024
Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancerJarey H Wang, Matthew P Deek, Adrianna A Mendes, et al.European Urology Oncology|June 11, 2024
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate CancerPhilip Sutera, Yang Song, Amol C Shetty, et al.European Urology Oncology|September 21, 2025
Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation TherapyPhilip Sutera, Kim Van der Eecken, Yang Song, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2022
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE TrialsMatthew P Deek, Kim Van der Eecken, Philip Sutera, et al.Pageof 4